Funding Details
- Awarder
- RSS - feed.businesswire.com
- Date Award
- August 07, 2024
- Vertical
- Contract Research Organization (CRO)
- Funding URL
- View Funding Page
Company Info
- Founding Year
- None
- Traction
- NovAliX has achieved substantial revenue from its collaborations with biopharma customers and drug-discovery partners, predominantly in Europe, and is now expanding in the United States and Japan.
- Organizations Involved
- Max Planck Institute
- Founders
- Stephan Jenn
- Company Description
- NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects.
- Market
- Biopharma
- Location
-
Strasbourg,
Grand Est,
France
- Coinvestors
- None
Links